137 related articles for article (PubMed ID: 23927961)
1. Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.
Ma D; Hovey RL; Zhang Z; Fye S; Huettner PC; Borecki IB; Rader JS
Gynecol Oncol; 2013 Nov; 131(2):445-50. PubMed ID: 23927961
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in immune mediators associate with risk of cervical cancer.
Zhang Z; Fye S; Borecki IB; Rader JS
Gynecol Oncol; 2014 Oct; 135(1):69-73. PubMed ID: 25127987
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
[TBL] [Abstract][Full Text] [Related]
5. Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction defects.
McBride KL; Zender GA; Fitzgerald-Butt SM; Seagraves NJ; Fernbach SD; Zapata G; Lewin M; Towbin JA; Belmont JW
Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91(3):162-8. PubMed ID: 21290564
[TBL] [Abstract][Full Text] [Related]
6. The Association between Epidermal Growth Factor Receptor Single Nucleotide Polymorphisms and Radiochemotherapy Response in Cervical Cancer.
Jin G; Fan XM; Li KX; Niu SH; Zhang QY
Pathol Oncol Res; 2020 Apr; 26(2):1255-1261. PubMed ID: 31254173
[TBL] [Abstract][Full Text] [Related]
7. The involvement of ErbB4 with schizophrenia: association and expression studies.
Silberberg G; Darvasi A; Pinkas-Kramarski R; Navon R
Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):142-8. PubMed ID: 16402353
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
9. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.
Zidi S; Gazouani E; Stayoussef M; Mezlini A; Ahmed SK; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2015 Dec; 76(2):343-347. PubMed ID: 26076679
[TBL] [Abstract][Full Text] [Related]
10. CD83 polymorphisms and cervical cancer risk.
Yu KJ; Rader JS; Borecki I; Zhang Z; Hildesheim A
Gynecol Oncol; 2009 Aug; 114(2):319-22. PubMed ID: 19446866
[TBL] [Abstract][Full Text] [Related]
11. TP53, MDM2, NQO1, and susceptibility to cervical cancer.
Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
13. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
[TBL] [Abstract][Full Text] [Related]
14. EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women.
Chen KY; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen YM; Huang MS; Hsiung CA; Chen CJ; Yang PC;
Carcinogenesis; 2013 Mar; 34(3):612-9. PubMed ID: 23239743
[TBL] [Abstract][Full Text] [Related]
15. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
Chen D; Gyllensten U
Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
[TBL] [Abstract][Full Text] [Related]
16. HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer.
Martin MP; Borecki IB; Zhang Z; Nguyen L; Ma D; Gao X; Qi Y; Carrington M; Rader JS
Immunogenetics; 2010 Dec; 62(11-12):761-5. PubMed ID: 20857097
[TBL] [Abstract][Full Text] [Related]
17. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
[TBL] [Abstract][Full Text] [Related]
18. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
19. [Association between Fas/Fas L genes promoter polymorphisms and pathogenic risk of cervical cancer].
Li H; Guo HY; Sun T; Zhou YF; Lin DX; Zhang WH; Qiao J
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):38-41. PubMed ID: 19538867
[TBL] [Abstract][Full Text] [Related]
20. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia.
Benzel I; Bansal A; Browning BL; Galwey NW; Maycox PR; McGinnis R; Smart D; St Clair D; Yates P; Purvis I
Behav Brain Funct; 2007 Jun; 3():31. PubMed ID: 17598910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
